vs

Side-by-side financial comparison of Bloom Energy Corp (BE) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Bloom Energy Corp is the larger business by last-quarter revenue ($751.1M vs $622.0M, roughly 1.2× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 9.4%, a 25.0% gap on every dollar of revenue. On growth, Bloom Energy Corp posted the faster year-over-year revenue change (130.4% vs 4.8%). Over the past eight quarters, Bloom Energy Corp's revenue compounded faster (51.7% CAGR vs 4.6%).

KR Sridhar is an Indian American engineer, inventor, professor, and entrepreneur. He is the founder, chairman, and chief executive officer (CEO) of Bloom Energy. Prior, Sridhar was a professor of Aerospace and Mechanical Engineering and the Director of the Space Technologies Laboratory (STL) at the University of Arizona. He worked with and advised NASA, and is a member of the National Academy of Engineering.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

BE vs RPRX — Head-to-Head

Bigger by revenue
BE
BE
1.2× larger
BE
$751.1M
$622.0M
RPRX
Growing faster (revenue YoY)
BE
BE
+125.6% gap
BE
130.4%
4.8%
RPRX
Higher net margin
RPRX
RPRX
25.0% more per $
RPRX
34.4%
9.4%
BE
Faster 2-yr revenue CAGR
BE
BE
Annualised
BE
51.7%
4.6%
RPRX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BE
BE
RPRX
RPRX
Revenue
$751.1M
$622.0M
Net Profit
$70.7M
$214.2M
Gross Margin
30.0%
Operating Margin
17.3%
62.4%
Net Margin
9.4%
34.4%
Revenue YoY
130.4%
4.8%
Net Profit YoY
2.9%
EPS (diluted)
$0.44
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BE
BE
RPRX
RPRX
Q1 26
$751.1M
Q4 25
$772.8M
$622.0M
Q3 25
$513.3M
$609.3M
Q2 25
$396.3M
$578.7M
Q1 25
$319.3M
$568.2M
Q4 24
$567.0M
$593.6M
Q3 24
$321.8M
$564.7M
Q2 24
$326.5M
$537.3M
Net Profit
BE
BE
RPRX
RPRX
Q1 26
$70.7M
Q4 25
$1.4M
$214.2M
Q3 25
$-23.0M
$288.2M
Q2 25
$-42.2M
$30.2M
Q1 25
$-23.4M
$238.3M
Q4 24
$105.2M
$208.2M
Q3 24
$-14.6M
$544.0M
Q2 24
$-61.2M
$102.0M
Gross Margin
BE
BE
RPRX
RPRX
Q1 26
30.0%
Q4 25
31.0%
Q3 25
29.5%
Q2 25
27.0%
Q1 25
27.8%
Q4 24
38.7%
Q3 24
24.5%
Q2 24
21.0%
Operating Margin
BE
BE
RPRX
RPRX
Q1 26
17.3%
Q4 25
11.3%
62.4%
Q3 25
1.5%
70.1%
Q2 25
-0.9%
36.3%
Q1 25
-6.0%
94.0%
Q4 24
18.5%
60.9%
Q3 24
-3.0%
Q2 24
-7.1%
50.2%
Net Margin
BE
BE
RPRX
RPRX
Q1 26
9.4%
Q4 25
0.2%
34.4%
Q3 25
-4.5%
47.3%
Q2 25
-10.6%
5.2%
Q1 25
-7.3%
41.9%
Q4 24
18.5%
35.1%
Q3 24
-4.5%
96.3%
Q2 24
-18.7%
19.0%
EPS (diluted)
BE
BE
RPRX
RPRX
Q1 26
$0.44
Q4 25
$99.91
$0.49
Q3 25
$-100.00
$0.67
Q2 25
$-0.18
$0.07
Q1 25
$-0.10
$0.55
Q4 24
$0.45
$0.46
Q3 24
$-0.06
$1.21
Q2 24
$-0.27
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BE
BE
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$618.7M
Total DebtLower is stronger
$9.0B
Stockholders' EquityBook value
$948.0K
$9.7B
Total Assets
$4.7B
$19.6B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BE
BE
RPRX
RPRX
Q1 26
Q4 25
$2.5B
$618.7M
Q3 25
$595.1M
$938.9M
Q2 25
$574.8M
$631.9M
Q1 25
$794.8M
$1.1B
Q4 24
$802.9M
$929.0M
Q3 24
$495.7M
$950.1M
Q2 24
$581.7M
$1.8B
Total Debt
BE
BE
RPRX
RPRX
Q1 26
Q4 25
$2.6B
$9.0B
Q3 25
$1.1B
$8.9B
Q2 25
$1.1B
$8.0B
Q1 25
$1.1B
$7.6B
Q4 24
$1.1B
$7.6B
Q3 24
$1.1B
$7.6B
Q2 24
$1.1B
$7.6B
Stockholders' Equity
BE
BE
RPRX
RPRX
Q1 26
$948.0K
Q4 25
$768.6M
$9.7B
Q3 25
$653.1M
$9.6B
Q2 25
$594.6M
$9.5B
Q1 25
$578.3M
$9.8B
Q4 24
$562.5M
$10.3B
Q3 24
$430.9M
$10.3B
Q2 24
$423.3M
$9.8B
Total Assets
BE
BE
RPRX
RPRX
Q1 26
$4.7B
Q4 25
$4.4B
$19.6B
Q3 25
$2.6B
$19.3B
Q2 25
$2.5B
$18.3B
Q1 25
$2.6B
$17.6B
Q4 24
$2.7B
$18.2B
Q3 24
$2.6B
$18.0B
Q2 24
$2.5B
$17.7B
Debt / Equity
BE
BE
RPRX
RPRX
Q1 26
Q4 25
3.41×
0.92×
Q3 25
1.73×
0.93×
Q2 25
1.91×
0.84×
Q1 25
1.96×
0.78×
Q4 24
2.01×
0.74×
Q3 24
2.62×
0.74×
Q2 24
2.66×
0.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BE
BE
RPRX
RPRX
Operating Cash FlowLast quarter
$827.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.86×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BE
BE
RPRX
RPRX
Q1 26
Q4 25
$418.1M
$827.1M
Q3 25
$19.7M
$702.6M
Q2 25
$-213.1M
$364.0M
Q1 25
$-110.7M
$596.1M
Q4 24
$484.2M
$742.5M
Q3 24
$-69.5M
$703.6M
Q2 24
$-175.5M
$658.2M
Free Cash Flow
BE
BE
RPRX
RPRX
Q1 26
Q4 25
$395.1M
Q3 25
$7.4M
Q2 25
$-220.4M
Q1 25
$-124.9M
Q4 24
$473.1M
Q3 24
$-83.8M
Q2 24
$-187.5M
FCF Margin
BE
BE
RPRX
RPRX
Q1 26
Q4 25
51.1%
Q3 25
1.4%
Q2 25
-55.6%
Q1 25
-39.1%
Q4 24
83.4%
Q3 24
-26.0%
Q2 24
-57.4%
Capex Intensity
BE
BE
RPRX
RPRX
Q1 26
Q4 25
3.0%
Q3 25
2.4%
Q2 25
1.8%
Q1 25
4.5%
Q4 24
2.0%
Q3 24
4.4%
Q2 24
3.7%
Cash Conversion
BE
BE
RPRX
RPRX
Q1 26
Q4 25
293.18×
3.86×
Q3 25
2.44×
Q2 25
12.06×
Q1 25
2.50×
Q4 24
4.60×
3.57×
Q3 24
1.29×
Q2 24
6.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BE
BE

Product$653.3M87%
Service$61.9M8%
Installation$25.9M3%
Electricity$9.9M1%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons